• Tate & Lyle expanded its collaboration with BioHarvest Sciences to accelerate development of multiple plant-based sweetener molecules.
• The move broadens a joint sweetener development program launched in 2024, reflecting technical progress and a push to offer category-specific sweetening options.
• The work uses BioHarvest’s Botanical Synthesis platform to develop plant-based, non-GMO ingredients, aiming to reduce reliance on agricultural extraction for scarce botanicals.
• The expanded scope is intended to strengthen Tate & Lyle’s next-generation sweetener pipeline as food and beverage customers seek sugar-like taste with lower calories and acceptable labeling.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tate & Lyle plc published the original content used to generate this news brief on May 18, 2026, and is solely responsible for the information contained therein.